Star Sports Medicine plans repurchase of up to 2.9 million H shares under buyback mandatePUBT·2 days ago, 04:20 AM01609+1.55%
Star Sports Medicine FY26 H1 profit drops 26.1% to RMB 27.4 million; revenue rises 21.6% to RMB 163.43 millionPUBT·Aug 17 at 05:15 AM01609+1.55%
Star Sports Medicine schedules board meeting to review interim results, weigh dividend recommendationPUBT·Aug 5 at 03:49 AM01609+1.55%
Star Sports Medicine proposes 2026 share incentive scheme with 10% issuance capPUBT·Aug 3 at 07:36 AM01609+1.55%
